PRECISION BIOSCIENCES INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
PRECISION BIOSCIENCES INC (DTIL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 21.38 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-06
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 370.00 shares, a 99.81% decline year-over-year.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 21.01K shares, a 2100.21% increase year-over-year.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 384.00 shares, a 98.89% decline year-over-year.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 7.17K shares, a 77.10% increase year-over-year.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 207.56K shares, a 256.97% increase from fiscal 2024.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 58.15K shares, a 53.37% decline from fiscal 2023.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 124.68K shares, a 45.36% increase from fiscal 2022.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 85.77K shares, a 94.11% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 370.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 21.38K shares 10-Q · filed 2026-08-06 | 21.77K shares derived: sum of 3 quarters · filed 2026-08-06 | 28.93K shares derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | 21.01K shares 10-Q · filed 2026-05-05 | 21.40K shares derived: sum of 2 quarters · filed 2026-05-05 | 28.57K shares derived: sum of 3 quarters · filed 2026-05-05 | 227.62K shares derived: sum of 4 quarters · filed 2026-05-05 | |
| 2025-12-31 | 384.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 7.55K shares derived: sum of 2 quarters · filed 2026-03-12 | 206.60K shares derived: sum of 3 quarters · filed 2026-03-12 | 207.56K shares 10-K · filed 2026-03-12 | |
| 2025-09-30 | 7.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | 206.22K shares derived: sum of 2 quarters · filed 2025-11-03 | 207.17K shares 10-Q · filed 2025-11-03 | 241.89K shares derived: sum of 4 quarters · filed 2026-03-12 | |
| 2025-06-30 | 199.05K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 200.00K shares 10-Q · filed 2025-08-07 | 234.72K shares derived: sum of 3 quarters · filed 2026-03-12 | 238.77K shares derived: sum of 4 quarters · filed 2026-03-12 | |
| 2025-03-31 | 955.00 shares 10-Q · filed 2025-05-15 | 35.67K shares derived: sum of 2 quarters · filed 2026-03-12 | 39.72K shares derived: sum of 3 quarters · filed 2026-03-12 | 44.50K shares derived: sum of 4 quarters · filed 2026-03-12 | |
| 2024-12-31 | 34.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 38.77K shares derived: sum of 2 quarters · filed 2026-03-12 | 43.55K shares derived: sum of 3 quarters · filed 2026-03-12 | 58.15K shares 10-K · filed 2026-03-12 | |
| 2024-09-30 | 4.05K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | 8.83K shares derived: sum of 2 quarters · filed 2024-11-04 | 23.43K shares 10-Q · filed 2024-11-04 | -2.42M shares derived: sum of 4 quarters · filed 2025-03-26 | |
| 2024-06-30 | 4.78K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 19.38K shares 10-Q · filed 2024-08-01 | -2.43M shares derived: sum of 3 quarters · filed 2025-03-26 | -1.47M shares derived: sum of 4 quarters · filed 2025-03-26 | |
| 2024-03-31 | 14.60K shares 10-Q · filed 2024-05-13 | -2.43M shares derived: sum of 2 quarters · filed 2025-03-26 | -1.47M shares derived: sum of 3 quarters · filed 2025-03-26 | -849.39K shares derived: sum of 4 quarters · filed 2025-03-26 | |
| 2023-12-31 | -2.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -1.48M shares derived: sum of 2 quarters · filed 2025-03-26 | -863.99K shares derived: sum of 3 quarters · filed 2025-03-26 | 124.68K shares 10-K · filed 2025-03-26 | 124.68K shares 10-K · filed 2024-03-27 |
| 2023-09-30 | 962.93K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 1.58M shares derived: sum of 2 quarters · filed 2023-11-07 | 2.57M shares 10-Q · filed 2023-11-07 | 686.33K shares derived: sum of 4 quarters · filed 2024-03-27 | |
| 2023-06-30 | 620.92K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | 1.61M shares 10-Q · filed 2023-08-04 | -276.60K shares derived: sum of 3 quarters · filed 2024-03-27 | 392.91K shares derived: sum of 4 quarters · filed 2024-03-27 | |
| 2023-03-31 | 988.67K shares 10-Q · filed 2023-05-09 | -897.52K shares derived: sum of 2 quarters · filed 2024-03-27 | -228.01K shares derived: sum of 3 quarters · filed 2024-03-27 | 334.63K shares derived: sum of 4 quarters · filed 2024-03-27 | |
| 2022-12-31 | -1.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -1.22M shares derived: sum of 2 quarters · filed 2024-03-27 | -654.04K shares derived: sum of 3 quarters · filed 2024-03-27 | 85.77K shares 10-K · filed 2024-03-27 | 2.58M shares 10-K · filed 2023-03-09 |
| 2022-09-30 | 669.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 1.23M shares derived: sum of 2 quarters · filed 2022-11-08 | 1.97M shares 10-Q · filed 2022-11-08 | 2.52M shares derived: sum of 4 quarters · filed 2023-03-09 | |
| 2022-06-30 | 562.63K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 1.30M shares 10-Q · filed 2022-08-08 | 1.85M shares derived: sum of 3 quarters · filed 2023-03-09 | 2.43M shares derived: sum of 4 quarters · filed 2023-03-09 | |
| 2022-03-31 | 739.82K shares 10-Q · filed 2022-05-09 | 1.28M shares derived: sum of 2 quarters · filed 2023-03-09 | 1.86M shares derived: sum of 3 quarters · filed 2023-03-09 | 2.03M shares derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-12-31 | 544.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 1.12M shares derived: sum of 2 quarters · filed 2023-03-09 | 1.29M shares derived: sum of 3 quarters · filed 2023-03-09 | 1.46M shares 10-K · filed 2023-03-09 | |
| 2021-09-30 | 579.87K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 742.42K shares derived: sum of 2 quarters · filed 2021-11-10 | 912.73K shares 10-Q · filed 2021-11-10 | 1.08M shares derived: sum of 4 quarters · filed 2022-03-15 | |
| 2021-06-30 | 162.54K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 332.86K shares 10-Q · filed 2021-08-12 | 500.62K shares derived: sum of 3 quarters · filed 2022-03-15 | 759.07K shares derived: sum of 4 quarters · filed 2022-03-15 | |
| 2021-03-31 | 170.32K shares 10-Q · filed 2021-05-13 | 338.07K shares derived: sum of 2 quarters · filed 2022-03-15 | 596.53K shares derived: sum of 3 quarters · filed 2022-03-15 | 1.04M shares derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-12-31 | 167.76K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 426.21K shares derived: sum of 2 quarters · filed 2022-03-15 | 872.85K shares derived: sum of 3 quarters · filed 2022-03-15 | 975.39K shares 10-K · filed 2022-03-15 | |
| 2020-09-30 | 258.45K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | 705.09K shares derived: sum of 2 quarters · filed 2020-11-10 | 807.63K shares 10-Q · filed 2020-11-10 | 972.51K shares derived: sum of 4 quarters · filed 2021-03-18 | |
| 2020-06-30 | 446.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 549.17K shares 10-Q · filed 2020-08-13 | 714.06K shares derived: sum of 3 quarters · filed 2021-03-18 | 819.90K shares derived: sum of 4 quarters · filed 2021-03-18 | |
| 2020-03-31 | 102.54K shares 10-Q · filed 2020-05-15 | 267.42K shares derived: sum of 2 quarters · filed 2021-03-18 | 373.27K shares derived: sum of 3 quarters · filed 2021-03-18 | 373.27K shares derived: sum of 4 quarters · filed 2021-03-18 | |
| 2019-12-31 | 164.89K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | 270.73K shares derived: sum of 2 quarters · filed 2021-03-18 | 270.73K shares derived: sum of 3 quarters · filed 2021-03-18 | 550.64K shares 10-K · filed 2021-03-18 | |
| 2019-09-30 | 105.84K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 105.84K shares derived: sum of 2 quarters · filed 2019-11-12 | 385.76K shares 10-Q · filed 2019-11-12 | ||
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 279.91K shares 10-Q · filed 2019-08-14 | |||
| 2019-03-31 | 279.91K shares 10-Q · filed 2019-04-29 | ||||
| 2018-12-31 | 592.35K shares 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |